Skip to Main Content

The Role of Resistant Starch in COVID-19 Infection

Conditions

COVID-19 Outpatient

Phase COVID-III

What is the purpose of this trial?

This study is a multicenter randomized trial to evaluate the efficacy of administering a dietary supplement containing resistant starch to non-hospitalized COVID-19 positive subjects, The intervention will begin as soon as possible after subjects test positive for COVID-19 and continue for 14 days. Investigators hypothesize that short-term administration of a dietary supplement containing resistant starch has the potential to reduce rates of hospitalization and improve time to clinical recovery and symptoms in non-hospitalized COVID-19 positive patients.

  • Trial with
    Pending
  • Start Date
    05/28/2020
  • End Date
    04/30/2021
Trial Image

For more information about this study, contact:

Tanima Arora

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Principal Investigator

Sub-Investigator

  • Last Updated
    06/02/2020
  • Study HIC
    #2000027887